The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evolve: A post PARP inhibitor clinical translational phase II trial of cediranib-olaparib in ovarian cancer—A Princess Margaret Consortium – GCIG Phase II Trial.
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - AstraZeneca (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Ana Oaknin
Employment - Vall d'Hebron University Hospital
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; ImmunoGen; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
 
Swati Garg
No Relationships to Disclose
 
Jeffrey Bruce
No Relationships to Disclose
 
Neesha C. Dhani
Honoraria - Celgene; Sanofi
Consulting or Advisory Role - Celgene; Incyte
 
Ainhoa Madariaga
No Relationships to Disclose
 
Luisa Bonilla
No Relationships to Disclose
 
Yeh Chen Lee
No Relationships to Disclose
 
Ilaria Colombo
Employment - Medtronic (I)
Stock and Other Ownership Interests - Medtronic (I)
 
Gita Bhat
No Relationships to Disclose
 
Valerie Bowering
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
Justin White
No Relationships to Disclose
 
Sarah Accardi
No Relationships to Disclose
 
Susie Tan
No Relationships to Disclose
 
Marsela Braunstein
Patents, Royalties, Other Intellectual Property - Patent pending, co-inventor, for diagnostic assay: Histone-gene signature is predictive of anthracycline benefit in breast cancer patients.; Patent pending, co-inventor: Immune-gene signature is predictive of anthracycline-containing chemotherapy benefit in breast cancer.
 
Katherine Karakasis
No Relationships to Disclose
 
Zhihui (Amy) Liu
No Relationships to Disclose
 
Trevor John Pugh
Honoraria - Chrysalis Biomedical Advisors; Merck; Prosigna
Consulting or Advisory Role - DynaCare
Research Funding - Boehringer Ingelheim (Inst)
Patents, Royalties, Other Intellectual Property - Combined hybrid-capture DNA sequencing for disease detection; Hybrid-capture sequencing for dete rmining immune cell clonality
 
Amit M. Oza
Honoraria - Intas
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro